FOX04-DRI

FOXO4‑DRI Research Peptide Overview

FOXO4‑DRI is one of the most studied senolytic peptides in longevity and aging research today. Unlike general purpose regenerative peptides, FOXO4‑DRI is prized for its targeted mechanism: it's designed to help researchers selectively clear senescent ("zombie") cells: the aged, dysfunctional cells that build up in tissues over time that are linked to inflammation, tissue decline, and age-related disease.

What Makes FOXO4‑DRI Unique

• Category: Senolytic research peptide (cell-penetrating)

• Primary research focus: Selective clearance of senescent cells via the FOXO4–p53 pathway

FOXO4‑DRI works by blocking a specific interaction between two proteins — FOXO4 and p53 — that senescent cells rely on to stay alive. In simple terms: senescent cells use this FOXO4–p53 "handshake" to avoid programmed cell death. FOXO4‑DRI is built to interrupt that handshake, which in study models causes senescent cells to self-destruct while leaving normal cells alone, a process often described in the literature as selective senescent cell apoptosis.

Key Research Applications

FOXO4‑DRI has become a go-to peptide across several fast-growing areas of aging and regenerative science:

• Skin, scarring & fibrosis research — Studies on keloid (scar tissue) models show FOXO4‑DRI can selectively eliminate senescent fibroblasts, positioning it as a tool for dermal aging and scar-tissue research.

• Hormone & reproductive aging research — In aging models, FOXO4‑DRI has been shown to improve the testicular microenvironment and support healthy testosterone levels by clearing senescent Leydig cells, of interest to researchers studying age-related hormonal decline.

• Cellular senescence & longevity science — As one of the original compounds to validate the "senolytic" concept in animal studies, FOXO4‑DRI remains a benchmark peptide in longevity, anti-aging, and cellular rejuvenation research.

NextGenPeps supplies FOXO4‑DRI as a high-purity research peptide intended strictly for controlled laboratory use. This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for human consumption, self-experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.